characterization of the palmitoylome

Circumvent Pharmaceuticals is a company formed with the mission of developing precision medicines for neurodegenerative disease, starting with Batten Disease. It has built a team of scientists and clinicians focused on diseases with predictive animal models and a clear clinical development path. Its research has uncovered insights into brain-cell dysfunction, including synaptic function, protein localization, lysosomal function, autophagy, the palmitoylome, and the synaptome. Its current drug programs target CLN1 Batten Disease and other rare neurologica

Read more

investigation of therapeutic strategies for modulating the palmitoylomeresearch and development of treatments for Batten Disease